Comments

Arbutus Biopharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Arbutus Biopharma (ABUS) operate in?

Arbutus Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

ABUSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$3.33

-0.06-1.77%

Pre-Market: 5:48 PM EDT

Arbutus Biopharma (ABUS) Forecast

News Earnings Arbutus Biopharma (ABUS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Arbutus Biopharma Stock Price, Quotes and Forecasts | NASDAQ:ABUS | Benzinga

Explore Arbutus Biopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ABUS.

Open	-
Close	-
Volume / Avg.	0 / 850.64K
Day Range	- - -
52 Wk Range	2.30 - 4.72
Market Cap	$631.01M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	5.63%
Days to Cover	7.07

Recent News

Walmart To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Alnylam's Concedes Its Patent Infringement Case Against Moderna's COVID-19 Vaccine

Alnylam Pharmaceuticals has conceded that Moderna's products do not infringe on its patents, as a court ruling determined. Both companies have agreed to dismiss the case without prejudice for possible future actions.

Vandana Singh

Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge

Delaware Judge favors Arbutus and Genevant Sciences in their patent dispute with Moderna over COVID-19 vaccine technology.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 850.64K
Day Range	- - -
52 Wk Range	2.30 - 4.72
Market Cap	$631.01M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	5.63%
Days to Cover	7.07

About

Sector

Healthcare

Industry

N/A

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commerci...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Arbutus Biopharma (ABUS) stock?

You can purchase shares of Arbutus Biopharma (NASDAQ:ABUS) through any online brokerage.

View our list of the best stock brokerages

Who are Arbutus Biopharma (ABUS) competitors?

There are no as such competitors for Arbutus Biopharma.

What is the forecast, or price target, for Arbutus Biopharma (ABUS) stock?

Arbutus Biopharma has a consensus price target of $5.50.

What is the current price for Arbutus Biopharma (ABUS)?

The stock price for Arbutus Biopharma (NASDAQ: ABUS) is $3.33 last updated March 24, 2025 at 5:48 PM EDT.

Does Arbutus Biopharma (ABUS) pay a dividend?

There are no upcoming dividends for Arbutus Biopharma.

When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?

Arbutus Biopharma’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is Arbutus Biopharma (ABUS) going to split?

There is no upcoming split for Arbutus Biopharma.

What sector and industry does Arbutus Biopharma (ABUS) operate in?

Arbutus Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.